A doctoral citation summarizes the nature of the independent research, provides a high-level overview of the study, states the significance of the work and says who will benefit from the findings in clear, non-specialized language, so that members of a lay audience will understand it.
|2008||Ubiquitous computing is the third wave of computing, where technology moves off the desktop and into the real world around us. Dr. Blackstock designed a common programming model for ubiquitous computing and through practical integration experience and prototypes provided strong evidence of the portability and interoperability benefits of his model.||Doctor of Philosophy in Computer Science (PhD)|
|2008||Dr. Cross has shown that the enzyme CD45 is an important regulator of dendritic cell responses to pathogens. This research highlights a novel role for CD45 in linking early and late immune responses.||Doctor of Philosophy in Microbiology and Immunology (PhD)|
|2008||Dr. Enns studied the way social capital relations in British Columbia?s rural, coastal communities are highly gender differentiated. Women were found to capitalize on their unique position and strong networks to access economic and social resources, enabling them and their families to remain in their communities despite ongoing economic instability.||Doctor of Philosophy in Sociology (PhD)|
|2008||Dr. Bolourani showed that genetic manipulation of specific amoeba provides an elegant approach for elucidating the function of the highly conserved intracellular signaling Ras proteins which are found in all nucleated cells. He provided some of the best evidence to date showing conslusively that two Ras proteins have distinct but crucial roles during cell aggregation.||Doctor of Philosophy in Microbiology and Immunology (PhD)|
|2008||Dr Moreno presented an alternative to traditional methods for designing and pricing "over-the-counter" financial products. An efficient numerical algorithm to estimate the price of such products is also presented. The research provides a modern approach to modelling a growing sector of the financial markets.||Doctor of Philosophy in Mathematics (PhD)|
|2008||Dr. Gibbs used state-of-the-art technology to characterize the development of unwanted antibodies in Interferon beta-treated multiple sclerosis patients. He was part of the first team of investigators in North America, outside of clinical trials, to show that patients who develop unwanted anti-Interferon antibodies lose the beneficial effects of Interferon-beta.||Doctor of Philosophy in Experimental Medicine (PhD)|